While CD8+ T cells have been a major focus in most studies of CAR T cells, recent studies have highlighted the potential for CD4+ T cells and macrophages as co-effectors to enhance the anti-tumor effect of adoptively transferred T cells [13–17]. This evidence concerns the gene CD8A and neoplasm.